Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
130005 trials found · Page 6427 of 6501
-
Heart failure drug study pulled before it started
Symptom relief CancelledThe goal of this randomized double-blind crossover study is to assess whether a morning dose of the extended release torsemide has a better efficacy than the ordinary immediate release torsemide to induce renal sodium excretion after a salty lunch in patients with stable heart fa…
Phase 2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug CKD-508 tested for safety in healthy people
Knowledge-focused CompletedThis Phase 1, randomized, parallel-group, placebo-controlled, double-blinded study aims to evaluate the safety, PK, and PD of CKD-508 when administered multiple times once daily to healthy participants.
Phase 1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Prediabetes drug study pulled before it began
Disease control CancelledThe goal of this clinical trial is to investigate whether metformin improves vascular function in individuals with prediabetes. The main questions it aims to answer are: 1. Does metformin improve large conduit artery endothelial function in individuals with prediabetes? 2. Does …
Phase 2 • Sponsor: Diana Jalal • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug ZP9830 enters first human safety study
Knowledge-focused Recruiting nowThe primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.
Phase 1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug ABBV-CLS-616 tested for safety in healthy people
Knowledge-focused CompletedThis is a Phase 1, first in human, randomized, four-part study to investigate the safety, tolerability, and pharmacokinetics of ABBV-CLS-616 after oral dosing in healthy volunteers.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Stem cell trial for rare bleeding disorder pulled before it began
Disease control CancelledThis study is a clinical study initiated by single-arm, single-center, multiple administration researchers. The main purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells in refractory ITP subjects. The subjects voluntarily signed the informed con…
Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Cricket flour snacks put to the test: do they really curb hunger?
Knowledge-focused CompletedThis randomized, single-blind, triple crossover study investigated the effects of baked snacks containing either cricket flour (Acheta domesticus), pea flour (both at 15%), or a wheat flour-based control. One hundred adult participants were recruited and consumed each of the thre…
Sponsor: University of Turin, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New drug LY4005130 tested in healthy people for first time
Knowledge-focused CompletedThe purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in healthy participants. The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be pe…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug PRX019 takes first step: safety check in healthy people
Knowledge-focused CompletedThe purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Phase 1 • Sponsor: Prothena Biosciences Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Do emails and texts get people to join gut health research?
Knowledge-focused CompletedThis study is a randomized controlled trial nested in the "Le French Gut" e-cohort aiming to test the efficacy of 4 reminder strategies (emails and/or SMS with standard and/or institutional wording) in increasing participation of inactive volunteers. This trial is led in collabo…
Sponsor: SKEZI • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Simple Eye-Closing trick may sharpen Pre-Surgery measurements
Knowledge-focused Recruiting nowCataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the procedure, refractive outcome and subsequent relative spectacles independency is gaining increasing impor…
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Pfizer compares two pill forms of new drug in small Healthy-Volunteer study
Knowledge-focused CompletedThe primary purpose of this study is to measure and compare the amount of study drug in your blood after a single dose of two formulations of study drug.
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New drug ALN-AGT01 RVR tested for safety in healthy people
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability and PK of single ascending doses of ALN-AGT01 RVR.
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:50 UTC
-
Healthy volunteers help Fine-Tune new drug formulation
Knowledge-focused CompletedPart 1 aims to investigate the relative bioavailability of a new formulation and to assess potential food effects following oral administration of SYT-510. Part 1 will then guide dosing in Part 2, a multiple dose study which aims to assess safety, tolerability and pharmacokinetic…
Phase 1 • Sponsor: Synendos Therapeutics AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New antibiotic combo tested in healthy volunteers
Knowledge-focused CompletedThis was a Phase 1, open-label, single-center Pharmacokinetic (PK) study to evaluate plasma and intrapulmonary pharmacokinetics (PK) of ceftibuten and ledaborbactam in healthy adult participants. Approximately 31 participants were planned to be enrolled in two groups, with appro…
Phase 1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Breathing muscle training may boost tongue power, small study hints
Knowledge-focused Recruiting nowThis study aims to investigate the effects of respiratory muscle training on tongue muscle function in healthy subjects. We hypothesize that respiratory muscle training can improve strength and endurance of the tongue muscles.
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
When you eat matters: study reveals meal Timing's impact on metabolism
Knowledge-focused CompletedThe overarching aim of this research is to study the effects of caloric content and timing of meals on measures of postprandial metabolism and cardiovascular response 1. Determine the effect of caloric content on measures of postprandial metabolic flexibility and pulse wave anal…
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New drug CDX-622 tested for safety in healthy people
Knowledge-focused CompletedThis is a study to determine the safety of CDX-622 in healthy participants.
Phase 1 • Sponsor: Celldex Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Withings study to test smart device blood pressure prediction
Knowledge-focused CancelledThe primary objective is to evaluate the accuracy to predict uncontrolled hypertension with Withings device data.
Sponsor: Withings • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Heart scans aim to uncover hidden damage in duchenne patients
Knowledge-focused CancelledThe purpose of this study is to describe the progression of tissular and functional myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC